Astellas Pharma
ALPMYDrugs in Pipeline
189
Phase 3 Programs
115
Upcoming Catalysts
3
Next Catalyst
Next month
Market Overview
Stock performance and key metrics
3 upcoming, 0 past
peficitinib
Psoriasis
FK199B
Sleep Initiation and Maintenance Disorders
tamsulosin hydrochloride OCAS 0.4 mg
Benign Prostatic Hyperplasia
Tacrolimus (Prograf®)
Rheumatoid Arthritis
daclizumab
Kidney Transplantation
caspofungin
Candidiasis, Oral
YM177
Post Operative Pain
VESIcare®
Urinary Bladder, Overactive
degarelix
Prostatic Neoplasms
enoxaparin
Venous Thromboembolism
Liposomal Amphotericin B
Candidiasis
nitrazepam
Sleep Initiation and Maintenance Disorders
Pembrolizumab
Urothelial Cancer
YM443
Indigestion
Solifenacin succinate suspension
Urinary Bladder, Overactive
Docetaxel
Metastatic Castration Resistant Prostate Cancer
Tacrolimus capsule
Myasthenia Gravis
Tacrolimus ointment 0.1%
Dermatitis, Atopic
YM529 / ONO-5920
Osteoporosis
Zolpidem MR
Sleep Initiation and Maintenance Disorders
mirabegron 25 mg
Urinary Bladder Diseases
FK506E (modified release tacrolimus)
Liver Transplantation
basiliximab
Kidney Transplantation
tolterodine ER
Urinary Bladder, Overactive
Corticosteroids
Liver Transplantation
Methotrexate
Rheumatoid Arthritis
Famotidine
Gastroesophageal Reflux
avacincaptad pegol
Geographic Atrophy
azacitidine
Acute Myeloid Leukemia (AML)
Ipragliflozin L-proline
Type 2 Diabetes Mellitus
Sevelamer hydrochloride
Hyperphosphatemia
oxaliplatin
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
febuxostat
Gout
Capsaicin 8%
Diabetic Peripheral Neuropathy
Tamoxifen
Hot Flashes
cyclosporine microemulsion
Kidney Transplantation
MR4
Kidney Transplantation
Tamuslosin
Urinary Tract Diseases
LoDAC (Low Dose Cytarabine)
Leukemia, Acute Myeloid (AML)
Interferon alfacon-1
Hepatitis C
Cytarabine
AML With FLT3 Mutation
Sulfonylurea
Type 2 Diabetes Mellitus
Ramosetron
Vomiting
DA
Chronic Kidney Disease
micafungin (Mycamine)
Fungemia
Tacrolimus
Asthma, Bronchial
Mirabegron
Neurogenic Detrusor Overactivity
Micafungin
Candidiasis, Oral
methylprednisolone and prednisone
Kidney Transplantation
alpha glucosidase inhibitor
Type 2 Diabetes Mellitus
OPT-80
Clostridium Difficile
Tacrolimus capsules
Lupus Nephritis
overencapsulated caffeine
Coronary Artery Disease (CAD)
ipragliflozin
Diabetes Mellitus
Tamusulosin
Urinary Tract Diseases
RSD1235
Atrial Fibrillation
Etanercept
Rheumatoid Arthritis
QUTENZA
Painful Diabetic Peripheral Neuropathy (PDPN)
Paclitaxel
Ovarian Cancer
ASP0113
Allogeneic Hematopoietic Cell Transplant
leuprorelin acetate
Prostate Cancer
Plaebo
Rheumatoid Arthritis (RA)
FK506MR capsule
Liver Transplantation
Advagraf
Heart Transplantation
Voriconazole
Aspergillosis
Tacrolimus, modified release
Kidney Transplantation
FK506E
Heart Transplantation
Alefacept
Psoriatic Arthritis
Epoetin alfa
Anemia
pudexacianinium chloride
Intraoperative Ureter Visualization
roxadustat
Hemodialysis Chronic Kidney Disease Patients With Anemia
Exisulind
NSCLC
Fidaxomicin oral suspension
Clostridium Difficile-associated Diarrhea (CDAD)
Capecitabine
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
tolterodine
Urinary Bladder, Overactive
Solifenacin succinate
Urinary Bladder, Overactive
YM178
Urinary Bladder, Overactive
Pioglitazone
Type 2 Diabetes Mellitus
nateglinide
Type 2 Diabetes Mellitus
Darbepoetin alfa
Anemia in Chronic Kidney Disease in Non-dialysis Patients
Fezolinetant
Hot Flashes
ASP8825
Restless Legs Syndrome
DPP-4 inhibitor
Type 2 Diabetes Mellitus
YM060
Irritable Bowel Syndrome
Enzalutamide
Progressive Metastatic Prostate Cancer
Cyclosporine
Heart Diseases
fluconazole
Invasive Candidiasis
ASP1585
Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia
Certolizumab pegol
Rheumatoid Arthritis
ASP1941
Type 2 Diabetes Mellitus
Tacrolimus Cream
Psoriasis
YM150
Arthroplasty, Replacement, Knee
tacrolimus ointment
Dermatitis, Atopic
FK949E
Bipolar Disorder
CDP870
Active Rheumatoid Arthritis
linaclotide
Irritable Bowel Syndrome With Constipation (IBS-C)
Prograf
Liver Transplantation
Goserelin
Prostate Cancer
isavuconazole
Aspergillosis
Tacrolimus modified-release
Liver Transplantation
zolbetuximab
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
prednisone
Metastatic Castration-Resistant Prostate Cancer
mycophenolate mofetil
KIDNEY TRANSPLANTATION
FK506
Keratoconjunctivitis
metformin
Type II Diabetes Mellitus
Steroids
De Novo Kidney Transplantation
tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg)
Lower Urinary Tract Symptoms
FK506MR
Kidney Transplantation
MMF
Kidney Transplantation
CZP
Rheumatoid Arthritis
Simulect
Kidney Transplantation
OSI-906
Adrenocortical Carcinoma
Androgen deprivation therapy (ADT)
Metastatic Hormone Sensitive Prostate Cancer
Gilteritinib
Advanced Solid Tumors
Prograf-XL
Liver Transplantation
Reldesemtiv
Chronic Obstructive Pulmonary Disease (COPD)
ASP1650
Incurable Platinum Refractory Germ Cell Tumors
Erlotinib
NSCLC
quetiapine extended release (XR)
Major Depressive Disorder
YM872 (zonampanel), t-PA (alteplase)
Acute Ischemic Stroke
ASP4070
Rhinitis, Allergic, Seasonal
ASP4901
Benign Prostate Hyperplasia
Tacrolimus Inhalation Aerosol
Asthma
ASP5541
Prostate Cancer
ASP8062
Fibromyalgia
ASP9831
Non-Alcoholic Steatohepatitis
Isavuconazonium sulfate
Invasive Mucormycosis
FK788
Hepatitis C
OSI-461
Chronic Lymphocytic Leukemia
AGS-1C4D4
Carcinoma, Pancreatic Ductal
ASP1517
Anemia in Chronic Kidney Disease Patients Not on Dialysis
abiraterone acetate
Prostate Cancer
ASP7991
Secondary Hyperparathyroidism
ASP5094
Rheumatoid Arthritis (RA)
ASP4345
Schizophrenia
FK614
Diabetes Mellitus
ASKP1240
Psoriasis
steroids, monoclonal anti-IL2R antibody
Hepatitis C
YM872 (zonampanel)
Cerebrovascular Accident
YM543
Diabetes Mellitus Type 2
nab-paclitaxel
Pancreatic Cancer
MDV3100
Prostate Cancer
enfortumab vedotin (EV)
Carcinoma, Transitional Cell
leucovorin
Pharmacokinetics of Zolbetuximab
Venetoclax
Acute Myeloid Leukemia (AML)
ASK8007
Rheumatoid Arthritis
ASP1570
Advanced Solid Tumors
FK463
Candidiasis
ASP6294
Bladder Pain Syndrome
FK778
Kidney Transplantation
ASP8302
Underactive Bladder
CP-461
Crohn's Disease
Methylprednisolone
X-Linked Myotubular Myopathy
Tacrolimus prolonged release
Intestine Transplantation
YM155
Lung Cancer
Anti-IL2R AB
Liver Transplantation
Midazolam
Acute Myeloid Leukemia
tamsulosin hydrochloride
Lower Urinary Tract Symptoms
tacrolimus modified release (MR)
Liver Transplantation
Tacrolimus Ointment 0.03%
Dermatitis, Atopic
Enfortumab vedotin
Metastatic Urothelial Cancer
warfarin
Atrial Fibrillation
ASP2151
Herpes Genitalis
ASP8477
Post-Herpetic Neuralgia (PHN)
ASP1707
Endometriosis
ASP7517
Acute Myeloid Leukemia (AML)
ASP8232
Diabetes Mellitus
Idarubicin
Acute Myeloid Leukemia
hydrocortisone acetate ointment 1%
Atopic Dermatitis
Valacyclovir hydrochloride
Herpes Zoster
regadenoson
Coronary Artery Disease (CAD)
ASP7962
Osteoarthritis of the Knee
ASP2246
Chronic Ischemic Stroke
epirubicin
CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction
AGS-16C3F
Metastatic Renal Cell Carcinoma
ASP3550
Prostatic Neoplasms
bicalutamide
Prostatic Neoplasms
VCL-CB01
Acute Lymphoblastic Leukemia
ASP3652
Chronic Abacterial Prostatitis
ASP1128
Acute Kidney Injury (AKI)
linsitinib
Advanced Solid Tumors
YM 155
Prostate Cancer
Bleselumab
Kidney Transplantation
ASP0456
Chronic Constipation
Mycophenolate Mofetil (MMF)
Kidney Transplantation
Sham
Stargardt's Macular Dystrophy
ASP0819
Fibromyalgia
OSI-211 (Liposomal Lurtotecan)
SCLC
MA09-hRPE
Stargardt's Macular Dystrophy
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
peficitinib | Phase 3 | Psoriasis | - | - |
FK199B | Phase 3 | Sleep Initiation and Maintenance Disorders | - | - |
tamsulosin hydrochloride OCAS 0.4 mg | Phase 3 | Benign Prostatic Hyperplasia | - | - |
Tacrolimus (Prograf®) | Phase 3 | Rheumatoid Arthritis | - | - |
daclizumab | Phase 3 | Kidney Transplantation | - | - |
caspofungin | Phase 3 | Candidiasis, Oral | - | - |
YM177 | Phase 3 | Post Operative Pain | - | - |
VESIcare® | Phase 3 | Urinary Bladder, Overactive | - | - |
degarelix | Phase 3 | Prostatic Neoplasms | - | - |
enoxaparin | Phase 3 | Venous Thromboembolism | - | - |
Liposomal Amphotericin B | Phase 3 | Candidiasis | - | - |
nitrazepam | Phase 3 | Sleep Initiation and Maintenance Disorders | - | - |
Pembrolizumab | Phase 3 | Urothelial Cancer | - | - |
YM443 | Phase 3 | Indigestion | - | - |
Solifenacin succinate suspension | Phase 3 | Urinary Bladder, Overactive | - | - |
Docetaxel | Phase 3 | Metastatic Castration Resistant Prostate Cancer | - | - |
Tacrolimus capsule | Phase 3 | Myasthenia Gravis | - | - |
Tacrolimus ointment 0.1% | Phase 3 | Dermatitis, Atopic | - | - |
YM529 / ONO-5920 | Phase 3 | Osteoporosis | - | - |
Zolpidem MR | Phase 3 | Sleep Initiation and Maintenance Disorders | - | - |
mirabegron 25 mg | Phase 3 | Urinary Bladder Diseases | - | - |
FK506E (modified release tacrolimus) | Phase 3 | Liver Transplantation | - | - |
basiliximab | Phase 3 | Kidney Transplantation | - | - |
tolterodine ER | Phase 3 | Urinary Bladder, Overactive | - | - |
Corticosteroids | Phase 3 | Liver Transplantation | - | - |
Methotrexate | Phase 3 | Rheumatoid Arthritis | - | - |
Famotidine | Phase 3 | Gastroesophageal Reflux | - | - |
avacincaptad pegol | Phase 3 | Geographic Atrophy | - | - |
azacitidine | Phase 3 | Acute Myeloid Leukemia (AML) | - | - |
Ipragliflozin L-proline | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Sevelamer hydrochloride | Phase 3 | Hyperphosphatemia | - | - |
oxaliplatin | Phase 3 | Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | - | - |
febuxostat | Phase 3 | Gout | - | - |
Capsaicin 8% | Phase 3 | Diabetic Peripheral Neuropathy | - | - |
Tamoxifen | Phase 3 | Hot Flashes | - | - |
cyclosporine microemulsion | Phase 3 | Kidney Transplantation | - | - |
MR4 | Phase 3 | Kidney Transplantation | - | - |
Tamuslosin | Phase 3 | Urinary Tract Diseases | - | - |
LoDAC (Low Dose Cytarabine) | Phase 3 | Leukemia, Acute Myeloid (AML) | - | - |
Interferon alfacon-1 | Phase 3 | Hepatitis C | - | - |
Cytarabine | Phase 3 | AML With FLT3 Mutation | - | - |
Sulfonylurea | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Ramosetron | Phase 3 | Vomiting | - | - |
DA | Phase 3 | Chronic Kidney Disease | - | - |
micafungin (Mycamine) | Phase 3 | Fungemia | - | - |
Tacrolimus | Phase 3 | Asthma, Bronchial | - | - |
Mirabegron | Phase 3 | Neurogenic Detrusor Overactivity | - | - |
Micafungin | Phase 3 | Candidiasis, Oral | - | - |
methylprednisolone and prednisone | Phase 3 | Kidney Transplantation | - | - |
alpha glucosidase inhibitor | Phase 3 | Type 2 Diabetes Mellitus | - | - |
OPT-80 | Phase 3 | Clostridium Difficile | - | - |
Tacrolimus capsules | Phase 3 | Lupus Nephritis | - | - |
overencapsulated caffeine | Phase 3 | Coronary Artery Disease (CAD) | - | - |
ipragliflozin | Phase 3 | Diabetes Mellitus | - | - |
Tamusulosin | Phase 3 | Urinary Tract Diseases | - | - |
RSD1235 | Phase 3 | Atrial Fibrillation | - | - |
Etanercept | Phase 3 | Rheumatoid Arthritis | - | - |
QUTENZA | Phase 3 | Painful Diabetic Peripheral Neuropathy (PDPN) | - | - |
Paclitaxel | Phase 3 | Ovarian Cancer | - | - |
ASP0113 | Phase 3 | Allogeneic Hematopoietic Cell Transplant | - | - |
leuprorelin acetate | Phase 3 | Prostate Cancer | - | - |
Plaebo | Phase 3 | Rheumatoid Arthritis (RA) | - | - |
FK506MR capsule | Phase 3 | Liver Transplantation | - | - |
Advagraf | Phase 3 | Heart Transplantation | - | - |
Voriconazole | Phase 3 | Aspergillosis | - | - |
Tacrolimus, modified release | Phase 3 | Kidney Transplantation | - | - |
FK506E | Phase 3 | Heart Transplantation | - | - |
Alefacept | Phase 3 | Psoriatic Arthritis | - | - |
Epoetin alfa | Phase 3 | Anemia | - | - |
pudexacianinium chloride | Phase 3 | Intraoperative Ureter Visualization | - | - |
roxadustat | Phase 3 | Hemodialysis Chronic Kidney Disease Patients With Anemia | - | - |
Exisulind | Phase 3 | NSCLC | - | - |
Fidaxomicin oral suspension | Phase 3 | Clostridium Difficile-associated Diarrhea (CDAD) | - | - |
Capecitabine | Phase 3 | Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | - | - |
tolterodine | Phase 3 | Urinary Bladder, Overactive | - | - |
Solifenacin succinate | Phase 3 | Urinary Bladder, Overactive | - | - |
YM178 | Phase 3 | Urinary Bladder, Overactive | - | - |
Pioglitazone | Phase 3 | Type 2 Diabetes Mellitus | - | - |
nateglinide | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Darbepoetin alfa | Phase 3 | Anemia in Chronic Kidney Disease in Non-dialysis Patients | - | - |
Fezolinetant | Phase 3 | Hot Flashes | - | - |
ASP8825 | Phase 3 | Restless Legs Syndrome | - | - |
DPP-4 inhibitor | Phase 3 | Type 2 Diabetes Mellitus | - | - |
YM060 | Phase 3 | Irritable Bowel Syndrome | - | - |
Enzalutamide | Phase 3 | Progressive Metastatic Prostate Cancer | - | - |
Cyclosporine | Phase 3 | Heart Diseases | - | - |
fluconazole | Phase 3 | Invasive Candidiasis | - | - |
ASP1585 | Phase 3 | Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia | - | - |
Certolizumab pegol | Phase 3 | Rheumatoid Arthritis | - | - |
ASP1941 | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Tacrolimus Cream | Phase 3 | Psoriasis | - | - |
YM150 | Phase 3 | Arthroplasty, Replacement, Knee | - | - |
tacrolimus ointment | Phase 3 | Dermatitis, Atopic | - | - |
FK949E | Phase 3 | Bipolar Disorder | - | - |
CDP870 | Phase 3 | Active Rheumatoid Arthritis | - | - |
linaclotide | Phase 3 | Irritable Bowel Syndrome With Constipation (IBS-C) | - | - |
Prograf | Phase 3 | Liver Transplantation | - | - |
Goserelin | Phase 3 | Prostate Cancer | - | - |
isavuconazole | Phase 3 | Aspergillosis | - | - |
Tacrolimus modified-release | Phase 3 | Liver Transplantation | - | - |
zolbetuximab | Phase 3 | Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | - | - |
prednisone | Phase 3 | Metastatic Castration-Resistant Prostate Cancer | - | - |
mycophenolate mofetil | Phase 3 | KIDNEY TRANSPLANTATION | - | - |
FK506 | Phase 3 | Keratoconjunctivitis | - | - |
metformin | Phase 3 | Type II Diabetes Mellitus | - | - |
Steroids | Phase 3 | De Novo Kidney Transplantation | - | - |
tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg) | Phase 3 | Lower Urinary Tract Symptoms | - | - |
FK506MR | Phase 3 | Kidney Transplantation | - | - |
MMF | Phase 3 | Kidney Transplantation | - | - |
CZP | Phase 3 | Rheumatoid Arthritis | - | - |
Simulect | Phase 3 | Kidney Transplantation | - | - |
OSI-906 | Phase 3 | Adrenocortical Carcinoma | - | - |
Androgen deprivation therapy (ADT) | Phase 3 | Metastatic Hormone Sensitive Prostate Cancer | - | - |
Gilteritinib | Phase 3 | Advanced Solid Tumors | - | - |
Prograf-XL | Phase 3 | Liver Transplantation | - | - |
Reldesemtiv | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
ASP1650 | Phase 2 | Incurable Platinum Refractory Germ Cell Tumors | - | - |
Erlotinib | Phase 2 | NSCLC | - | - |
quetiapine extended release (XR) | Phase 2 | Major Depressive Disorder | - | - |
YM872 (zonampanel), t-PA (alteplase) | Phase 2 | Acute Ischemic Stroke | - | - |
ASP4070 | Phase 2 | Rhinitis, Allergic, Seasonal | - | - |
ASP4901 | Phase 2 | Benign Prostate Hyperplasia | - | - |
Tacrolimus Inhalation Aerosol | Phase 2 | Asthma | - | - |
ASP5541 | Phase 2 | Prostate Cancer | - | - |
ASP8062 | Phase 2 | Fibromyalgia | - | - |
ASP9831 | Phase 2 | Non-Alcoholic Steatohepatitis | - | - |
Isavuconazonium sulfate | Phase 2 | Invasive Mucormycosis | - | - |
FK788 | Phase 2 | Hepatitis C | - | - |
OSI-461 | Phase 2 | Chronic Lymphocytic Leukemia | - | - |
AGS-1C4D4 | Phase 2 | Carcinoma, Pancreatic Ductal | - | - |
ASP1517 | Phase 2 | Anemia in Chronic Kidney Disease Patients Not on Dialysis | - | - |
abiraterone acetate | Phase 2 | Prostate Cancer | - | - |
ASP7991 | Phase 2 | Secondary Hyperparathyroidism | - | - |
ASP5094 | Phase 2 | Rheumatoid Arthritis (RA) | - | - |
ASP4345 | Phase 2 | Schizophrenia | - | - |
FK614 | Phase 2 | Diabetes Mellitus | - | - |
ASKP1240 | Phase 2 | Psoriasis | - | - |
steroids, monoclonal anti-IL2R antibody | Phase 2 | Hepatitis C | - | - |
YM872 (zonampanel) | Phase 2 | Cerebrovascular Accident | - | - |
YM543 | Phase 2 | Diabetes Mellitus Type 2 | - | - |
nab-paclitaxel | Phase 2 | Pancreatic Cancer | - | - |
MDV3100 | Phase 2 | Prostate Cancer | - | - |
enfortumab vedotin (EV) | Phase 2 | Carcinoma, Transitional Cell | - | - |
leucovorin | Phase 2 | Pharmacokinetics of Zolbetuximab | - | - |
Venetoclax | Phase 2 | Acute Myeloid Leukemia (AML) | - | - |
ASK8007 | Phase 2 | Rheumatoid Arthritis | - | - |
ASP1570 | Phase 2 | Advanced Solid Tumors | - | - |
FK463 | Phase 2 | Candidiasis | - | - |
ASP6294 | Phase 2 | Bladder Pain Syndrome | - | - |
FK778 | Phase 2 | Kidney Transplantation | - | - |
ASP8302 | Phase 2 | Underactive Bladder | - | - |
CP-461 | Phase 2 | Crohn's Disease | - | - |
Methylprednisolone | Phase 2 | X-Linked Myotubular Myopathy | - | - |
Tacrolimus prolonged release | Phase 2 | Intestine Transplantation | - | - |
YM155 | Phase 2 | Lung Cancer | - | - |
Anti-IL2R AB | Phase 2 | Liver Transplantation | - | - |
Midazolam | Phase 2 | Acute Myeloid Leukemia | - | - |
tamsulosin hydrochloride | Phase 2 | Lower Urinary Tract Symptoms | - | - |
tacrolimus modified release (MR) | Phase 2 | Liver Transplantation | - | - |
Tacrolimus Ointment 0.03% | Phase 2 | Dermatitis, Atopic | - | - |
Enfortumab vedotin | Phase 2 | Metastatic Urothelial Cancer | - | - |
warfarin | Phase 2 | Atrial Fibrillation | - | - |
ASP2151 | Phase 2 | Herpes Genitalis | - | - |
ASP8477 | Phase 2 | Post-Herpetic Neuralgia (PHN) | - | - |
ASP1707 | Phase 2 | Endometriosis | - | - |
ASP7517 | Phase 2 | Acute Myeloid Leukemia (AML) | - | - |
ASP8232 | Phase 2 | Diabetes Mellitus | - | - |
Idarubicin | Phase 2 | Acute Myeloid Leukemia | - | - |
hydrocortisone acetate ointment 1% | Phase 2 | Atopic Dermatitis | - | - |
Valacyclovir hydrochloride | Phase 2 | Herpes Zoster | - | - |
regadenoson | Phase 2 | Coronary Artery Disease (CAD) | - | - |
ASP7962 | Phase 2 | Osteoarthritis of the Knee | - | - |
ASP2246 | Phase 2 | Chronic Ischemic Stroke | - | - |
epirubicin | Phase 2 | CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction | - | - |
AGS-16C3F | Phase 2 | Metastatic Renal Cell Carcinoma | - | - |
ASP3550 | Phase 2 | Prostatic Neoplasms | - | - |
bicalutamide | Phase 2 | Prostatic Neoplasms | - | - |
VCL-CB01 | Phase 2 | Acute Lymphoblastic Leukemia | - | - |
ASP3652 | Phase 2 | Chronic Abacterial Prostatitis | - | - |
ASP1128 | Phase 2 | Acute Kidney Injury (AKI) | - | - |
linsitinib | Phase 2 | Advanced Solid Tumors | - | - |
YM 155 | Phase 2 | Prostate Cancer | - | - |
Bleselumab | Phase 2 | Kidney Transplantation | - | - |
ASP0456 | Phase 2 | Chronic Constipation | - | - |
Mycophenolate Mofetil (MMF) | Phase 2 | Kidney Transplantation | - | - |
Sham | Phase 2 | Stargardt's Macular Dystrophy | - | - |
ASP0819 | Phase 2 | Fibromyalgia | - | - |
OSI-211 (Liposomal Lurtotecan) | Phase 2 | SCLC | - | - |
MA09-hRPE | Phase 2 | Stargardt's Macular Dystrophy | - | - |
Clostridium Difficile
1 drug in this indication
Kidney Transplantation
1 drug in this indication
Incurable Platinum Refractory Germ Cell Tumors
1 drug in this indication
Post Operative Pain
1 drug in this indication
Fungemia
1 drug in this indication
NSCLC
1 drug in this indication
Major Depressive Disorder
1 drug in this indication
Urinary Bladder, Overactive
1 drug in this indication
Acute Ischemic Stroke
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)